Regtechtimes on MSN
Clinical proof that travels: The state of evidence first operations in 2026
Biosimilars have stopped being a specialty conversation and become a day-to-day operational test. A pharmacist wants to know whether substitution is safe. A payer wants to know whether outcomes match ...
India, April 16 -- India must digitize procurement and build healthcare reserves to secure HIV prevention against global and ...
Opioid dependence, characterized by high relapse rates and substantial social harm, represents a major global public health ...
To address AI bias at its roots, we must understand the human heuristics that shape it. Unlike prior frameworks that focus ...
Nowhere is this convergence more evident than in the emerging field of sensory augmentation, where artificial intelligence ...
A recent study published in the Journal of Bioresources and Bioproducts reports the development of a water-soluble cellulose ethyl phosphite (CEP) adhesive synthesized via a CO2-based solvent system.
HIV-1 envelope glycoprotein (Env), a gp120–gp41 trimer, undergoes coordinated conformational changes that drive membrane fusion and allow immune evasion by transiently concealing ...
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results